Quick Takeaways
- Freebird Partners LP filed SCHEDULE 13G/A for Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA).
- Disclosed ownership: 9.9%.
- Date of event: 31 Mar 2025.
Freebird Partners LP - 31 Mar 2025 SCHEDULE 13G/A Report for Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA)
- Filing Manager
- Freebird Partners LP
- Reporting Manager
- Freebird Partners LP
- Symbol
- ERNA
- Shares outstanding
- 62,742,727 shares
- Disclosed Ownership
- 6,211,530 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 May 2025, 14:14:23 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 28 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Freebird Partners LP disclosed 9.9% ownership in Ernexa Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 28 Jan 2025.
- Current filing was accepted on 14 May 2025, 14:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Freebird Partners LP | 9.9% | 6,211,530 | 0 | 6,211,530 | /s/ Curtis Huff | Curtis Huff, Chairman and President | |
| Freebird Investments LLC | 9.9% | 6,211,530 | 0 | 6,211,530 | /s/ Curtis Huff | Curtis Huff, Chairman and President | |
| Curtis Huff | 9.9% | 6,211,530 | 0 | 6,211,530 | /s/ Curtis Huff | Curtis Huff |